The use of high resolution melting analysis to detect Fabry mutations in heterozygous females via dry bloodspots.
暂无分享,去创建一个
Jan-Gowth Chang | Hong-Duo Chen | D. Niu | S. Kao | Yu-Hsiu Huang | Chia-Feng Yang | Hsiao-Chi Yu | J. Suen | Fang-Chih Tsai | T. Wu | Ching-Yuang Lin | Mei-Ying Liu | Chang-Long Tai | Chiang-Chuan Chiang | H. Chiang | Hong-duo Chen | Mei‐Ying Liu
[1] Shih-Jen Chen,et al. Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A) , 2010, Journal of Inherited Metabolic Disease.
[2] Shing‐Jong Lin,et al. High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population , 2009, Circulation. Cardiovascular genetics.
[3] R. Vossen,et al. High‐Resolution Melting Analysis (HRMA)—More than just sequence variant screening , 2009, Human mutation.
[4] Carl T Wittwer,et al. High‐resolution DNA melting analysis: advancements and limitations , 2009, Human mutation.
[5] E. Silverman,et al. High-resolution melting curve analysis of genomic and whole-genome amplified DNA. , 2008, Clinical chemistry.
[6] Karl V Voelkerding,et al. High resolution melting applications for clinical laboratory medicine. , 2008, Experimental and molecular pathology.
[7] J. Yagüe,et al. Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy , 2007 .
[8] E. Lyon,et al. Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. , 2007, The Journal of molecular diagnostics : JMD.
[9] Carl T Wittwer,et al. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. , 2007, Pharmacogenomics.
[10] A. Quattrone,et al. Gene symbol: NOTCH3. , 2007, Human genetics.
[11] P. Bauer,et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study , 2005, The Lancet.
[12] K. Tomita,et al. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. , 2005, Clinical nephrology.
[13] R. Kramar,et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. , 2004, Journal of the American Society of Nephrology : JASN.
[14] C. Eng,et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. , 2003, Kidney international.
[15] C. N. Gundry,et al. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. , 2003, Clinical chemistry.
[16] P. Elliott,et al. Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy , 2002, Circulation.
[17] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[18] P. Meikle,et al. Prevalence of lysosomal storage disorders. , 1999, JAMA.
[19] H. Sakuraba,et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. , 1995, The New England journal of medicine.
[20] C. Eng,et al. An atypical variant of Fabry's disease with manifestations confined to the myocardium. , 1991, The New England journal of medicine.
[21] J. Ellison,et al. Novel human pathological mutations. Gene symbol: PTEN. Disease: PTEN Hamartoma Tumour Syndrome. , 2010, Human Genetics.
[22] M. A. Al Balwi,et al. Novel human pathological mutations. Gene symbol: MAN2B1. Disease: Mannosidosis, alpha. , 2010, Human Genetics.
[23] Carl T. Wittwer,et al. High-Resolution Melting Curve Analysis for Molecular Diagnostics , 2010 .
[24] Y. Chien,et al. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease. , 2009, Human genetics.
[25] K. Hsiao,et al. A novel mutation (c. 1072_1074delGAG) in the alpha-galactosidase gene of a Taiwanese family with Fabry disease. , 2004, Acta Dermato-Venereologica.
[26] K. Hsiao,et al. Identification of a novel point mutation (S65T) in α‐galactosidase A gene in Chinese patients with Fabry disease , 1998 .